Revision of a method quality rating scale for single-case experimental designs and n-of-1 trials: The 15-item Risk of Bias in N-of-1 Trials (RoBiNT) Scale
Recent literature suggests a revival of interest in single-case methodology (e.g., the randomised n-of-1 trial is now considered Level 1 evidence for treatment decision purposes by the Oxford Centre for Evidence-Based Medicine). Consequently, the availability of tools to critically appraise single-c...
Saved in:
Published in | Neuropsychological rehabilitation Vol. 23; no. 5; pp. 619 - 638 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Hove
Routledge
01.10.2013
Psychology Press Taylor & Francis Ltd |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Recent literature suggests a revival of interest in single-case methodology (e.g., the randomised n-of-1 trial is now considered Level 1 evidence for treatment decision purposes by the Oxford Centre for Evidence-Based Medicine). Consequently, the availability of tools to critically appraise single-case reports is of great importance. We report on a major revision of our method quality instrument, the Single-Case Experimental Design Scale. Three changes resulted in a radically revised instrument, now entitled the Risk of Bias in N-of-1 Trials (RoBiNT) Scale: (i) item content was revised and increased to 15 items, (ii) two subscales were developed for internal validity (IV; 7 items) and external validity and interpretation (EVI; 8 items), and (iii) the scoring system was changed from a 2-point to 3-point scale to accommodate currently accepted standards. Psychometric evaluation indicated that the RoBiNT Scale showed evidence of construct (discriminative) validity. Inter-rater reliability was excellent, for pairs of both experienced and trained novice raters. Intraclass correlation coefficients of summary scores for individual (experienced) raters: ICC
TotalScore
= .90, ICC
IVSubscale
= .88, ICC
EVISubscale
= .87; individual (novice) raters: ICC
TotalScore
= .88, ICC
IVSubscale
= .87, ICC
EVISubscale
= .93; consensus ratings between experienced and novice raters (ICC
TotalScore
= .95, ICC
IVSubscale
= .93, ICC
EVISubscale
= .93. The RoBiNT Scale thus shows sound psychometric properties and provides a comprehensive yet efficient examination of important features of single-case methodology. |
---|---|
AbstractList | Recent literature suggests a revival of interest in single-case methodology (e.g., the randomised n-of-1 trial is now considered Level 1 evidence for treatment decision purposes by the Oxford Centre for Evidence-Based Medicine). Consequently, the availability of tools to critically appraise single-case reports is of great importance. We report on a major revision of our method quality instrument, the Single-Case Experimental Design Scale. Three changes resulted in a radically revised instrument, now entitled the Risk of Bias in N-of-1 Trials (RoBiNT) Scale: (i) item content was revised and increased to 15 items, (ii) two subscales were developed for internal validity (IV; 7 items) and external validity and interpretation (EVI; 8 items), and (iii) the scoring system was changed from a 2-point to 3-point scale to accommodate currently accepted standards. Psychometric evaluation indicated that the RoBiNT Scale showed evidence of construct (discriminative) validity. Inter-rater reliability was excellent, for pairs of both experienced and trained novice raters. Intraclass correlation coefficients of summary scores for individual (experienced) raters: ICC(TotalScore) = .90, ICC(IVSubscale) = .88, ICC(EVISubscale) = .87; individual (novice) raters: ICC(TotalScore)= .88, ICC(IVSubscale) = .87, ICC(EVISubscale) = .93; consensus ratings between experienced and novice raters (ICC(TotalScore) = .95, ICC(IVSubscale) = .93, ICC(EVISubscale) = .93. The RoBiNT Scale thus shows sound psychometric properties and provides a comprehensive yet efficient examination of important features of single-case methodology.Recent literature suggests a revival of interest in single-case methodology (e.g., the randomised n-of-1 trial is now considered Level 1 evidence for treatment decision purposes by the Oxford Centre for Evidence-Based Medicine). Consequently, the availability of tools to critically appraise single-case reports is of great importance. We report on a major revision of our method quality instrument, the Single-Case Experimental Design Scale. Three changes resulted in a radically revised instrument, now entitled the Risk of Bias in N-of-1 Trials (RoBiNT) Scale: (i) item content was revised and increased to 15 items, (ii) two subscales were developed for internal validity (IV; 7 items) and external validity and interpretation (EVI; 8 items), and (iii) the scoring system was changed from a 2-point to 3-point scale to accommodate currently accepted standards. Psychometric evaluation indicated that the RoBiNT Scale showed evidence of construct (discriminative) validity. Inter-rater reliability was excellent, for pairs of both experienced and trained novice raters. Intraclass correlation coefficients of summary scores for individual (experienced) raters: ICC(TotalScore) = .90, ICC(IVSubscale) = .88, ICC(EVISubscale) = .87; individual (novice) raters: ICC(TotalScore)= .88, ICC(IVSubscale) = .87, ICC(EVISubscale) = .93; consensus ratings between experienced and novice raters (ICC(TotalScore) = .95, ICC(IVSubscale) = .93, ICC(EVISubscale) = .93. The RoBiNT Scale thus shows sound psychometric properties and provides a comprehensive yet efficient examination of important features of single-case methodology. Recent literature suggests a revival of interest in single-case methodology (e.g., the randomised n-of-1 trial is now considered Level 1 evidence for treatment decision purposes by the Oxford Centre for Evidence-Based Medicine). Consequently, the availability of tools to critically appraise single-case reports is of great importance. We report on a major revision of our method quality instrument, the Single-Case Experimental Design Scale. Three changes resulted in a radically revised instrument, now entitled the Risk of Bias in N-of-1 Trials (RoBiNT) Scale: (i) item content was revised and increased to 15 items, (ii) two subscales were developed for internal validity (IV; 7 items) and external validity and interpretation (EVI; 8 items), and (iii) the scoring system was changed from a 2-point to 3-point scale to accommodate currently accepted standards. Psychometric evaluation indicated that the RoBiNT Scale showed evidence of construct (discriminative) validity. Inter-rater reliability was excellent, for pairs of both experienced and trained novice raters. Intraclass correlation coefficients of summary scores for individual (experienced) raters: ICCTotalScore = .90, ICCIVSubscale = .88, ICCEVISubscale = .87; individual (novice) raters: ICCTotalScore = .88, ICCIVSubscale = .87, ICCEVISubscale = .93; consensus ratings between experienced and novice raters (ICCTotalScore = .95, ICCIVSubscale = .93, ICCEVISubscale = .93. The RoBiNT Scale thus shows sound psychometric properties and provides a comprehensive yet efficient examination of important features of single-case methodology. Adapted from the source document. Recent literature suggests a revival of interest in single-case methodology (e.g., the randomised n-of-1 trial is now considered Level 1 evidence for treatment decision purposes by the Oxford Centre for Evidence-Based Medicine). Consequently, the availability of tools to critically appraise single-case reports is of great importance. We report on a major revision of our method quality instrument, the Single-Case Experimental Design Scale. Three changes resulted in a radically revised instrument, now entitled the Risk of Bias in N-of-1 Trials (RoBiNT) Scale: (i) item content was revised and increased to 15 items, (ii) two subscales were developed for internal validity (IV; 7 items) and external validity and interpretation (EVI; 8 items), and (iii) the scoring system was changed from a 2-point to 3-point scale to accommodate currently accepted standards. Psychometric evaluation indicated that the RoBiNT Scale showed evidence of construct (discriminative) validity. Inter-rater reliability was excellent, for pairs of both experienced and trained novice raters. Intraclass correlation coefficients of summary scores for individual (experienced) raters: ICCTotalScore = .90, ICCIVSubscale = .88, ICCEVISubscale = .87; individual (novice) raters: ICCTotalScore = .88, ICCIVSubscale = .87, ICCEVISubscale = .93; consensus ratings between experienced and novice raters (ICCTotalScore = .95, ICCIVSubscale = .93, ICCEVISubscale = .93. The RoBiNT Scale thus shows sound psychometric properties and provides a comprehensive yet efficient examination of important features of single-case methodology. [PUBLICATION ABSTRACT] Recent literature suggests a revival of interest in single-case methodology (e.g., the randomised n-of-1 trial is now considered Level 1 evidence for treatment decision purposes by the Oxford Centre for Evidence-Based Medicine). Consequently, the availability of tools to critically appraise single-case reports is of great importance. We report on a major revision of our method quality instrument, the Single-Case Experimental Design Scale. Three changes resulted in a radically revised instrument, now entitled the Risk of Bias in N-of-1 Trials (RoBiNT) Scale: (i) item content was revised and increased to 15 items, (ii) two subscales were developed for internal validity (IV; 7 items) and external validity and interpretation (EVI; 8 items), and (iii) the scoring system was changed from a 2-point to 3-point scale to accommodate currently accepted standards. Psychometric evaluation indicated that the RoBiNT Scale showed evidence of construct (discriminative) validity. Inter-rater reliability was excellent, for pairs of both experienced and trained novice raters. Intraclass correlation coefficients of summary scores for individual (experienced) raters: ICC TotalScore = .90, ICC IVSubscale = .88, ICC EVISubscale = .87; individual (novice) raters: ICC TotalScore = .88, ICC IVSubscale = .87, ICC EVISubscale = .93; consensus ratings between experienced and novice raters (ICC TotalScore = .95, ICC IVSubscale = .93, ICC EVISubscale = .93. The RoBiNT Scale thus shows sound psychometric properties and provides a comprehensive yet efficient examination of important features of single-case methodology. Recent literature suggests a revival of interest in single-case methodology (e.g., the randomised n-of-1 trial is now considered Level 1 evidence for treatment decision purposes by the Oxford Centre for Evidence-Based Medicine). Consequently, the availability of tools to critically appraise single-case reports is of great importance. We report on a major revision of our method quality instrument, the Single-Case Experimental Design Scale. Three changes resulted in a radically revised instrument, now entitled the Risk of Bias in N-of-1 Trials (RoBiNT) Scale: (i) item content was revised and increased to 15 items, (ii) two subscales were developed for internal validity (IV; 7 items) and external validity and interpretation (EVI; 8 items), and (iii) the scoring system was changed from a 2-point to 3-point scale to accommodate currently accepted standards. Psychometric evaluation indicated that the RoBiNT Scale showed evidence of construct (discriminative) validity. Inter-rater reliability was excellent, for pairs of both experienced and trained novice raters. Intraclass correlation coefficients of summary scores for individual (experienced) raters: ICC sub(TotalScore) = .90, ICC sub(IVSubscale) = .88, ICC sub(EVISubscale) = .87; individual (novice) raters: ICC sub(TotalScore) = .88, ICC sub(IVSubscale) = .87, ICC sub(EVISubscale) = .93; consensus ratings between experienced and novice raters (ICC sub(TotalScore) = .95, ICC sub(IVSubscale) = .93, ICC sub(EVISubscale) = .93. The RoBiNT Scale thus shows sound psychometric properties and provides a comprehensive yet efficient examination of important features of single-case methodology. Recent literature suggests a revival of interest in single-case methodology (e.g., the randomised n-of-1 trial is now considered Level 1 evidence for treatment decision purposes by the Oxford Centre for Evidence-Based Medicine). Consequently, the availability of tools to critically appraise single-case reports is of great importance. We report on a major revision of our method quality instrument, the Single-Case Experimental Design Scale. Three changes resulted in a radically revised instrument, now entitled the Risk of Bias in N-of-1 Trials (RoBiNT) Scale: (i) item content was revised and increased to 15 items, (ii) two subscales were developed for internal validity (IV; 7 items) and external validity and interpretation (EVI; 8 items), and (iii) the scoring system was changed from a 2-point to 3-point scale to accommodate currently accepted standards. Psychometric evaluation indicated that the RoBiNT Scale showed evidence of construct (discriminative) validity. Inter-rater reliability was excellent, for pairs of both experienced and trained novice raters. Intraclass correlation coefficients of summary scores for individual (experienced) raters: ICC(TotalScore) = .90, ICC(IVSubscale) = .88, ICC(EVISubscale) = .87; individual (novice) raters: ICC(TotalScore)= .88, ICC(IVSubscale) = .87, ICC(EVISubscale) = .93; consensus ratings between experienced and novice raters (ICC(TotalScore) = .95, ICC(IVSubscale) = .93, ICC(EVISubscale) = .93. The RoBiNT Scale thus shows sound psychometric properties and provides a comprehensive yet efficient examination of important features of single-case methodology. |
Author | McDonald, Skye Tate, Robyn L Godbee, Kali Wakim, Donna Perdices, Michael Togher, Leanne Rosenkoetter, Ulrike |
Author_xml | – sequence: 1 givenname: Robyn L surname: Tate fullname: Tate, Robyn L email: rtate@med.usyd.edu.au organization: Royal Rehabilitation Centre Sydney – sequence: 2 givenname: Michael surname: Perdices fullname: Perdices, Michael organization: Department of Psychological Medicine , University of Sydney – sequence: 3 givenname: Ulrike surname: Rosenkoetter fullname: Rosenkoetter, Ulrike organization: Rehabilitation Studies Unit, Sydney Medical School - Northern , University of Sydney – sequence: 4 givenname: Donna surname: Wakim fullname: Wakim, Donna organization: Rehabilitation Studies Unit, Sydney Medical School - Northern , University of Sydney – sequence: 5 givenname: Kali surname: Godbee fullname: Godbee, Kali organization: Rehabilitation Studies Unit, Sydney Medical School - Northern , University of Sydney – sequence: 6 givenname: Leanne surname: Togher fullname: Togher, Leanne organization: Speech Pathology, Faculty of Health Sciences , University of Sydney – sequence: 7 givenname: Skye surname: McDonald fullname: McDonald, Skye organization: School of Psychology , University of New South Wales |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=27801078$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/24050810$$D View this record in MEDLINE/PubMed |
BookMark | eNqN0s1u1DAQB3ALFdFt4Q0QsoSQyiGLJ3ESpxdEK76kqkjLco689qR1Seyt7QX2VXhaHLILUg-US6Ikv7En4_8RObDOIiFPgc2BCfaKNRXLGcA8XYq5yHkhigdkBrziGasafkBmI8lGc0iOQrhhDATj1SNymHNWMgFsRn4u8JsJxlnqOirpgPHaaXq7kb2JW-plNPaKBiV7pJ3zNKTHHjMlA1L8sUZvBrRR9lRjMFc2UGk1tZnrMqDRG9mHU7q8RgplZiIOdGHC13GnMyMDNZZeTnT5m9KThTszl8uX9PO44WPysEtv8cnufky-vHu7PP-QXXx6__H8zUWmuKhjVlQgdK2A1byuamCybHiec-hQs6bDKmccNSolkReQvpS1Xq10VSjWlXmzaopjcjKtu_budoMhtoMJCvteWnSb0EIJOTQgGrifpuEnLUT5H7TgNU_NjQ08v0Nv3Mbb9M-TqhiHUT3bqc1qQN2u0-yl37b7s0zgxQ7I8cA6L60y4a-rBUtDEsnxySnvQvDY_SHA2jFa7T5a7RitdopWKju9U6ZMTPlwNnpp-vuKX0_FxqYYDfK7871uo9z2zu8bLf65wi_j5eEx |
CODEN | NREHE3 |
CitedBy_id | crossref_primary_10_1016_j_apmr_2024_07_010 crossref_primary_10_1016_j_jpain_2023_03_013 crossref_primary_10_1080_02687038_2014_985884 crossref_primary_10_1212_WNL_0000000000011597 crossref_primary_10_2522_ptj_2016_96_7_e1 crossref_primary_10_1016_j_ridd_2018_03_003 crossref_primary_10_1186_s13643_017_0525_4 crossref_primary_10_1080_17437199_2017_1316672 crossref_primary_10_1080_09602011_2014_927368 crossref_primary_10_1080_09602011_2019_1696212 crossref_primary_10_1080_11038128_2024_2444591 crossref_primary_10_1177_0741932517729508 crossref_primary_10_1016_j_ebr_2024_100681 crossref_primary_10_1080_09602011_2023_2181191 crossref_primary_10_3758_s13428_023_02230_1 crossref_primary_10_3917_anpsy1_191_0055 crossref_primary_10_1016_j_arrct_2023_100260 crossref_primary_10_2196_48503 crossref_primary_10_1111_1460_6984_12942 crossref_primary_10_1002_jeab_799 crossref_primary_10_1016_j_jsp_2016_04_001 crossref_primary_10_1080_02699052_2018_1458335 crossref_primary_10_3390_cancers13215428 crossref_primary_10_3758_s13428_022_01858_9 crossref_primary_10_1016_j_anpsic_2017_05_004 crossref_primary_10_1089_neu_2022_0434 crossref_primary_10_1080_09602011_2016_1255230 crossref_primary_10_11124_JBIES_23_00139 crossref_primary_10_1186_s12984_020_00788_x crossref_primary_10_1016_j_jvoice_2021_03_026 crossref_primary_10_1177_0008417416648124 crossref_primary_10_1080_09602011_2018_1485110 crossref_primary_10_1371_journal_pdig_0000183 crossref_primary_10_3109_17549507_2015_1024169 crossref_primary_10_1177_0141076817721131 crossref_primary_10_1016_j_beproc_2021_104461 crossref_primary_10_1044_2021_LSHSS_20_00005 crossref_primary_10_1080_02687038_2018_1491192 crossref_primary_10_1080_09602011_2018_1488746 crossref_primary_10_3390_jcm11102757 crossref_primary_10_1080_02699052_2020_1831072 crossref_primary_10_1080_09602011_2017_1365730 crossref_primary_10_3758_s13428_016_0714_4 crossref_primary_10_1080_09602011_2022_2114503 crossref_primary_10_3109_17549507_2015_1126640 crossref_primary_10_1177_0145445519863035 crossref_primary_10_1177_02711214241281383 crossref_primary_10_3389_fpsyg_2016_00032 crossref_primary_10_1016_j_ridd_2018_04_029 crossref_primary_10_1002_bin_1875 crossref_primary_10_1080_09362835_2016_1196441 crossref_primary_10_1007_s40474_023_00290_8 crossref_primary_10_1044_2024_AJSLP_24_00287 crossref_primary_10_1080_09602011_2022_2096080 crossref_primary_10_1111_dmcn_15759 crossref_primary_10_1177_20597991221077910 crossref_primary_10_1097_HTR_0000000000000795 crossref_primary_10_3389_fmed_2025_1493832 crossref_primary_10_1080_17489539_2020_1741842 crossref_primary_10_1111_dmcn_15513 crossref_primary_10_3758_s13428_018_1165_x crossref_primary_10_1080_09602011_2016_1270837 crossref_primary_10_1177_0145445515603706 crossref_primary_10_1080_17489539_2022_2139148 crossref_primary_10_1111_bjet_13468 crossref_primary_10_5334_pb_1307 crossref_primary_10_1044_2024_JSLHR_23_00026 crossref_primary_10_1186_s12883_024_03699_9 crossref_primary_10_1080_09602011_2019_1653936 crossref_primary_10_1017_BrImp_2021_32 crossref_primary_10_1002_eat_22887 crossref_primary_10_1177_0741932517726143 crossref_primary_10_3390_healthcare7040143 crossref_primary_10_1016_j_beth_2024_01_008 crossref_primary_10_1007_s40614_021_00289_9 crossref_primary_10_1159_000505265 crossref_primary_10_1017_S1352465822000224 crossref_primary_10_1186_s13643_021_01589_6 crossref_primary_10_5014_ajot_2016_704002 crossref_primary_10_1044_2014_AJSLP_13_0035 crossref_primary_10_1080_09638288_2023_2221459 crossref_primary_10_2106_JBJS_RVW_23_00077 crossref_primary_10_1016_j_brat_2019_01_005 crossref_primary_10_1186_s13643_023_02255_9 crossref_primary_10_1080_09602011_2014_903198 crossref_primary_10_1080_09602011_2014_903199 crossref_primary_10_1080_09602011_2015_1064452 crossref_primary_10_1080_09602011_2017_1310658 crossref_primary_10_1017_BrImp_2022_32 crossref_primary_10_1080_09602011_2016_1190533 crossref_primary_10_1026_1616_3443_a000665 crossref_primary_10_1186_s40814_022_01153_6 crossref_primary_10_1080_09602011_2024_2345410 crossref_primary_10_1186_s12887_023_04189_6 crossref_primary_10_1177_02692155231218813 crossref_primary_10_3758_s13428_023_02303_1 crossref_primary_10_1007_s10578_021_01237_z crossref_primary_10_1016_j_jbct_2024_100502 crossref_primary_10_1177_0145445519837726 crossref_primary_10_1002_jcv2_12181 crossref_primary_10_1212_WNL_0000000000012998 crossref_primary_10_1080_02687038_2014_987051 crossref_primary_10_1186_s13023_023_02756_9 crossref_primary_10_1080_02687038_2014_1000613 crossref_primary_10_1038_s41393_024_01057_7 crossref_primary_10_1080_02699052_2019_1631482 crossref_primary_10_1080_07317115_2025_2481124 crossref_primary_10_1186_s13047_020_00400_4 crossref_primary_10_1016_j_jcbs_2021_05_005 crossref_primary_10_1044_2023_JSLHR_22_00665 crossref_primary_10_1186_s12879_023_08304_x crossref_primary_10_1080_17483107_2019_1604828 crossref_primary_10_1111_bph_16100 crossref_primary_10_1017_BrImp_2017_17 crossref_primary_10_1017_BrImp_2017_16 crossref_primary_10_2196_16066 crossref_primary_10_1038_s41572_018_0052_1 crossref_primary_10_1016_j_jclinepi_2024_111460 crossref_primary_10_1186_s12888_023_05422_3 crossref_primary_10_1016_j_jclinepi_2016_04_006 crossref_primary_10_1136_bmjopen_2024_089319 crossref_primary_10_3233_PRM_230019 crossref_primary_10_1111_epi_18068 crossref_primary_10_1007_s10880_019_09620_8 crossref_primary_10_1016_j_jphys_2020_06_004 crossref_primary_10_1080_17489539_2019_1645982 crossref_primary_10_1017_BrImp_2017_25 crossref_primary_10_1080_09602011_2014_915856 crossref_primary_10_1007_s40489_016_0091_z crossref_primary_10_1080_17489539_2020_1738625 crossref_primary_10_1186_s13023_021_02003_z crossref_primary_10_1017_ipm_2017_23 crossref_primary_10_1080_09602011_2013_875043 crossref_primary_10_1080_09602011_2020_1838301 crossref_primary_10_1016_j_jpain_2021_10_003 crossref_primary_10_1136_bmjopen_2021_059152 crossref_primary_10_1097_HTR_0000000000000068 crossref_primary_10_1007_s11065_023_09607_1 crossref_primary_10_1017_BrImp_2017_34 crossref_primary_10_1177_0145445515593512 crossref_primary_10_1080_09602011_2015_1113997 crossref_primary_10_3758_s13428_013_0440_0 crossref_primary_10_1136_bmjopen_2023_073854 crossref_primary_10_1016_j_jbmt_2023_11_063 crossref_primary_10_1080_02699052_2018_1531313 crossref_primary_10_3310_hsdr08450 crossref_primary_10_5964_meth_9209 crossref_primary_10_1080_09602011_2024_2444999 crossref_primary_10_1016_j_rehab_2019_12_010 crossref_primary_10_1044_2024_AJSLP_23_00215 crossref_primary_10_1136_bmjopen_2020_041745 crossref_primary_10_1016_j_rehab_2021_101535 crossref_primary_10_1038_s41591_021_01519_y crossref_primary_10_3389_fpsyg_2023_1195765 crossref_primary_10_1016_j_rehab_2023_101777 crossref_primary_10_1016_j_ridd_2018_05_008 crossref_primary_10_1016_j_psychsport_2019_101570 crossref_primary_10_1111_jsr_13843 crossref_primary_10_1371_journal_pone_0228077 crossref_primary_10_1080_09602011_2024_2331840 crossref_primary_10_1080_17549507_2022_2097310 crossref_primary_10_1080_09602011_2015_1102746 crossref_primary_10_1016_j_apmr_2015_08_424 crossref_primary_10_1007_s10488_024_01363_5 crossref_primary_10_1111_cp_12118 crossref_primary_10_1080_09638288_2020_1780637 crossref_primary_10_1136_bmjopen_2022_071262 crossref_primary_10_1007_s40614_020_00263_x crossref_primary_10_1080_09638288_2021_1925752 crossref_primary_10_1080_09602011_2016_1140657 crossref_primary_10_1080_09638288_2021_1989062 crossref_primary_10_1177_0145445518806867 crossref_primary_10_1080_09602011_2020_1842214 crossref_primary_10_1136_bmjopen_2021_060206 crossref_primary_10_1002_ejp_1631 crossref_primary_10_1111_jir_12780 crossref_primary_10_1080_17489539_2022_2040164 crossref_primary_10_1002_jaba_923 crossref_primary_10_1080_09638288_2016_1219400 crossref_primary_10_1016_j_jcomdis_2016_02_004 crossref_primary_10_1016_j_prps_2019_03_001 crossref_primary_10_3233_NRE_161342 crossref_primary_10_3109_17518423_2015_1100688 crossref_primary_10_3390_nu16142243 crossref_primary_10_1080_19404158_2019_1596138 crossref_primary_10_1177_1558689818789530 crossref_primary_10_1080_13854046_2013_873083 crossref_primary_10_1017_BrImp_2018_9 crossref_primary_10_1212_WNL_0000000000011603 crossref_primary_10_1016_j_jvoice_2023_10_033 crossref_primary_10_1080_09602011_2020_1786410 crossref_primary_10_1136_bmjopen_2023_081571 crossref_primary_10_1016_j_apmr_2019_05_023 crossref_primary_10_1097_HTR_0000000000000942 crossref_primary_10_1111_aas_14295 crossref_primary_10_1007_s10567_023_00432_9 crossref_primary_10_1016_j_rehab_2017_12_002 crossref_primary_10_1044_2017_AJSLP_16_0197 crossref_primary_10_3233_NRE_161347 crossref_primary_10_1080_17518423_2019_1645226 crossref_primary_10_1177_0145445516664307 crossref_primary_10_3109_17549507_2014_979880 crossref_primary_10_2196_10451 crossref_primary_10_1080_09602011_2022_2053169 crossref_primary_10_1007_s40489_023_00371_9 crossref_primary_10_1080_09602011_2018_1433049 crossref_primary_10_1080_09602011_2022_2070506 crossref_primary_10_1016_j_apmr_2016_03_023 crossref_primary_10_1089_neur_2024_0076 crossref_primary_10_3390_jcm11123525 crossref_primary_10_2196_35884 crossref_primary_10_1080_1750984X_2023_2258383 crossref_primary_10_1177_14713012251323941 crossref_primary_10_3758_s13428_020_01417_0 crossref_primary_10_3389_fonc_2015_00071 crossref_primary_10_1016_j_jclinepi_2016_03_023 crossref_primary_10_1007_s40732_020_00402_5 crossref_primary_10_1080_09602011_2022_2107545 crossref_primary_10_1080_02687038_2020_1812031 crossref_primary_10_3389_fnhum_2016_00562 crossref_primary_10_1016_j_conctc_2021_100715 crossref_primary_10_1080_09602011_2023_2190129 crossref_primary_10_1177_0145445519854323 crossref_primary_10_1080_09602011_2022_2111314 crossref_primary_10_1016_j_jclinepi_2015_05_004 crossref_primary_10_1186_s13063_022_06968_5 crossref_primary_10_1177_0741932516652893 crossref_primary_10_1177_0741932517716899 crossref_primary_10_1080_21642850_2019_1711096 crossref_primary_10_1017_BrImp_2014_25 crossref_primary_10_1017_S1352465820000788 crossref_primary_10_1017_BrImp_2014_28 crossref_primary_10_1136_bmjopen_2022_067593 crossref_primary_10_1080_17489539_2016_1190525 crossref_primary_10_3390_ijerph19031509 crossref_primary_10_3758_s13428_020_01502_4 crossref_primary_10_1044_2020_AJSLP_20_00131 crossref_primary_10_1016_j_conctc_2021_100826 crossref_primary_10_1080_02687038_2023_2282659 crossref_primary_10_1080_09638288_2022_2138573 crossref_primary_10_3109_09638288_2016_1141241 crossref_primary_10_1080_09602011_2020_1768127 crossref_primary_10_1080_09602011_2021_1971094 crossref_primary_10_1352_1944_7558_126_2_114 crossref_primary_10_1016_j_jclinepi_2015_05_018 crossref_primary_10_1016_j_prps_2018_11_001 crossref_primary_10_1016_j_jcbs_2024_100801 crossref_primary_10_1177_0308022616640299 crossref_primary_10_1080_17489539_2019_1597444 crossref_primary_10_1016_j_beth_2016_04_008 crossref_primary_10_1044_2018_JSLHR_L_18_0057 crossref_primary_10_1097_HTR_0000000000000580 crossref_primary_10_1111_1460_6984_12841 crossref_primary_10_3758_s13428_020_01345_z |
Cites_doi | 10.1080/09602010343000182 10.1080/07434619412331276920 10.1007/s10864-006-9036-4 10.1177/0741932512452794 10.1177/001440290507100203 10.1080/10413200.2012.720640 10.1901/jaba.1982.15-477 10.1375/brim.12.1.33 10.1016/j.jclinepi.2008.10.009 10.3109/00365528809099154 10.1080/09602010802009201 10.1177/002221949302601001 10.1080/09602010903040691 10.1056/NEJM198604033141406 10.7326/0003-4819-112-4-293 10.3758/s13428-011-0111-y 10.1136/bmj.39590.732037.47 10.1111/j.1752-7325.2011.00233.x 10.1007/s11065-006-9013-7 10.1037/0022-0167.34.4.437 10.1037/1040-3590.6.4.284 10.1016/j.jclinepi.2010.03.004 10.1016/j.jclinepi.2003.12.010 10.1177/1053815111418235 10.1177/0741932512468038 10.1037/0022-006X.73.5.852 10.1371/journal.pmed.0040061 10.1016/j.jsp.2011.05.001 10.1037/a0017736 10.1097/00002060-199903000-00022 10.1089/acm.2004.10.979 10.1093/ptj/83.8.713 10.1901/jaba.1977.10-349 |
ContentType | Journal Article |
Copyright | Copyright Taylor & Francis Group, LLC 2013 2015 INIST-CNRS Copyright Taylor & Francis Group, LLC |
Copyright_xml | – notice: Copyright Taylor & Francis Group, LLC 2013 – notice: 2015 INIST-CNRS – notice: Copyright Taylor & Francis Group, LLC |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7QJ 7TK 7TS K9. NAPCQ 7X8 |
DOI | 10.1080/09602011.2013.824383 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Applied Social Sciences Index & Abstracts (ASSIA) Neurosciences Abstracts Physical Education Index ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Applied Social Sciences Index and Abstracts (ASSIA) Neurosciences Abstracts Physical Education Index MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Applied Social Sciences Index and Abstracts (ASSIA) ProQuest Health & Medical Complete (Alumni) Neurosciences Abstracts MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1464-0694 |
EndPage | 638 |
ExternalDocumentID | 3078877891 24050810 27801078 10_1080_09602011_2013_824383 824383 |
Genre | Journal Article |
GroupedDBID | --- .7I .QK 0BK 0R~ 123 29N 2QV 36B 4.4 5VS AAGZJ AAMFJ AAMIU AAPUL AATTQ AAWTL AAZMC ABCCY ABDBF ABFIM ABIVO ABJNI ABLIJ ABPEM ABRYG ABTAI ABXUL ABXYU ABZLS ACGEJ ACGFO ACGFS ACPRK ACTIO ACTOA ACUHS ADAHI ADCVX ADKVQ ADXPE AECIN AEGXH AEISY AEKEX AENEX AEOZL AEPSL AEYOC AEZRU AFHDM AGDLA AGMYJ AGRBW AHDZW AHMBA AIAGR AIJEM AJWEG AKBVH ALMA_UNASSIGNED_HOLDINGS ALQZU AVBZW AWYRJ BEJHT BLEHA BMOTO BOHLJ CCCUG CQ1 CS3 DGFLZ DKSSO DU5 DXH EAP EBD EBS EJD EMK EPL EPS ESX E~B E~C F5P FEDTE FMBMU FXNIP G-F GTTXZ H13 HF~ HVGLF HZ~ IPNFZ J.O KRBQP KSSTO KWAYT KYCEM LGLTD M4Z MLAFT NA5 NW- O9- P2P PQQKQ RIG RNANH ROSJB RSYQP S-F STATR TBQAZ TEH TFH TFL TFW TNTFI TRJHH TUROJ UT5 UT9 VAE ~01 ~S~ .GJ 07M 1TA 4B3 53G AAGDL AAHIA AANPH AAYXX ABVXC ABWZE ACIKQ ACPKE ACRBO ADEWX ADIUE ADXAZ ADYSH AEFOU AEXSR AFRVT AIXGP AIYEW ALLRG AMPGV C5A CAG CBZAQ CITATION CKOZC COF C~T DGXZK EFRLQ EGDCR JLMOS L7Y LJTGL QZZOY RBICI TBH TDBHL UA1 ZY4 AAAVI ABJVF ABPTK ABPTX ABQHQ ABSSG ABTAH ACLSK AEGYZ AFOLD AFWLO FUNRP IQODW KDLKA V1K CGR CUY CVF ECM EIF NPM TASJS 7QJ 7TK 7TS K9. NAPCQ 7X8 |
ID | FETCH-LOGICAL-c487t-3618d7c107476710a5942241fed09fe6204edeccae43142257dbbd63c0f529b93 |
ISSN | 0960-2011 1464-0694 |
IngestDate | Fri Jul 11 09:25:29 EDT 2025 Fri Jul 11 01:09:39 EDT 2025 Mon Jul 21 11:12:10 EDT 2025 Sat Jul 26 02:08:15 EDT 2025 Mon Jul 21 05:48:25 EDT 2025 Sun Oct 22 16:07:57 EDT 2023 Thu Apr 24 23:07:07 EDT 2025 Tue Jul 01 00:35:02 EDT 2025 Wed Dec 25 09:01:39 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | Human Methodology Evaluation scale M-of-1 trial Evidence-based practice Internal validity Single-case experimental design Experimental study Evidence-based medicine Case study Validity Treatment Risk of bias Experimental design Quality Risk factor Methodological bias |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c487t-3618d7c107476710a5942241fed09fe6204edeccae43142257dbbd63c0f529b93 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 |
PMID | 24050810 |
PQID | 1434760419 |
PQPubID | 436415 |
PageCount | 20 |
ParticipantIDs | proquest_miscellaneous_1464512885 proquest_journals_1434760419 crossref_primary_10_1080_09602011_2013_824383 pubmed_primary_24050810 proquest_miscellaneous_1434742049 pascalfrancis_primary_27801078 informaworld_taylorfrancis_310_1080_09602011_2013_824383 proquest_miscellaneous_1512191891 crossref_citationtrail_10_1080_09602011_2013_824383 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2013-10-01 |
PublicationDateYYYYMMDD | 2013-10-01 |
PublicationDate_xml | – month: 10 year: 2013 text: 2013-10-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Hove |
PublicationPlace_xml | – name: Hove – name: England |
PublicationTitle | Neuropsychological rehabilitation |
PublicationTitleAlternate | Neuropsychol Rehabil |
PublicationYear | 2013 |
Publisher | Routledge Psychology Press Taylor & Francis Ltd |
Publisher_xml | – name: Routledge – name: Psychology Press – name: Taylor & Francis Ltd |
References | CIT0030 CIT0010 CIT0032 CIT0012 CIT0034 CIT0033 Hersen M. (CIT0019) 1976 Maher C. G. (CIT0031) 2003; 83 Guyatt G. (CIT0017) 1988; 139 Tate R. (CIT0044) CIT0014 Howick J. (CIT0022) 2011 CIT0036 CIT0035 CIT0016 CIT0038 CIT0037 CIT0018 CIT0039 Barlow D. H. (CIT0003) 1984 Gast D. L. (CIT0013) 2010 CIT0040 CIT0043 Kazdin A. E. (CIT0025) 2011 CIT0042 CIT0023 CIT0045 Higgins J. P. T. (CIT0020) 2011 Barlow D. H. (CIT0004) 2009 Guyatt G. (CIT0015) 2002 Horner R. H. (CIT0021) 2005; 71 Kazdin A. E. (CIT0024) 1982 Anastasi A. (CIT0001) 1997 CIT0047 CIT0002 CIT0046 CIT0005 CIT0027 CIT0026 CIT0048 CIT0007 CIT0029 CIT0006 CIT0028 CIT0009 CIT0008 |
References_xml | – ident: CIT0043 doi: 10.1080/09602010343000182 – volume-title: Single case experimental designs: Strategies for studying behavior for change year: 2009 ident: CIT0004 – volume: 139 start-page: 497 year: 1988 ident: CIT0017 publication-title: Canadian Medical Association Journal – volume-title: Cochrane handbook for systematic reviews of interventions year: 2011 ident: CIT0020 – volume-title: Single subject research methodology in behavioural sciences year: 2010 ident: CIT0013 – ident: CIT0037 doi: 10.1080/07434619412331276920 – volume-title: BEhavioural interventions (SCRIBE): Explanation and elaboration ident: CIT0044 – ident: CIT0030 doi: 10.1007/s10864-006-9036-4 – ident: CIT0028 doi: 10.1177/0741932512452794 – volume: 71 start-page: 165 issue: 2 year: 2005 ident: CIT0021 publication-title: Exceptional Children doi: 10.1177/001440290507100203 – volume-title: Single-case research designs. Methods for clinical and applied settings year: 2011 ident: CIT0025 – start-page: 179 volume-title: User's guides to the medical literature year: 2002 ident: CIT0015 – ident: CIT0033 doi: 10.1080/10413200.2012.720640 – ident: CIT0027 – volume-title: Psychological Testing year: 1997 ident: CIT0001 – ident: CIT0036 doi: 10.1901/jaba.1982.15-477 – ident: CIT0045 doi: 10.1375/brim.12.1.33 – volume-title: Single case research designs: Methods for clinical and applied settings year: 1982 ident: CIT0024 – ident: CIT0039 doi: 10.1016/j.jclinepi.2008.10.009 – ident: CIT0026 doi: 10.3109/00365528809099154 – volume-title: The 2011 Oxford CEBM Evidence Table (Introductory Document) year: 2011 ident: CIT0022 – ident: CIT0042 doi: 10.1080/09602010802009201 – ident: CIT0048 doi: 10.1177/002221949302601001 – ident: CIT0035 doi: 10.1080/09602010903040691 – ident: CIT0018 doi: 10.1056/NEJM198604033141406 – ident: CIT0016 doi: 10.7326/0003-4819-112-4-293 – ident: CIT0038 doi: 10.3758/s13428-011-0111-y – ident: CIT0014 doi: 10.1136/bmj.39590.732037.47 – ident: CIT0006 doi: 10.1111/j.1752-7325.2011.00233.x – volume-title: Single case experimental designs: Strategies for studying behavior for change year: 1984 ident: CIT0003 – ident: CIT0005 doi: 10.1007/s11065-006-9013-7 – ident: CIT0012 doi: 10.1037/0022-0167.34.4.437 – ident: CIT0010 doi: 10.1037/1040-3590.6.4.284 – ident: CIT0034 doi: 10.1016/j.jclinepi.2010.03.004 – ident: CIT0009 doi: 10.1016/j.jclinepi.2003.12.010 – ident: CIT0047 doi: 10.1177/1053815111418235 – ident: CIT0046 doi: 10.1177/0741932512468038 – ident: CIT0007 doi: 10.1037/0022-006X.73.5.852 – ident: CIT0008 doi: 10.1371/journal.pmed.0040061 – ident: CIT0032 doi: 10.1016/j.jsp.2011.05.001 – ident: CIT0029 doi: 10.1037/a0017736 – ident: CIT0002 doi: 10.1097/00002060-199903000-00022 – ident: CIT0023 doi: 10.1089/acm.2004.10.979 – volume: 83 start-page: 713 year: 2003 ident: CIT0031 publication-title: Physical Therapy doi: 10.1093/ptj/83.8.713 – volume-title: Single case experimental designs: Strategies for studying behaviour change year: 1976 ident: CIT0019 – ident: CIT0040 doi: 10.1901/jaba.1977.10-349 |
SSID | ssj0018046 |
Score | 2.4898884 |
Snippet | Recent literature suggests a revival of interest in single-case methodology (e.g., the randomised n-of-1 trial is now considered Level 1 evidence for treatment... |
SourceID | proquest pubmed pascalfrancis crossref informaworld |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 619 |
SubjectTerms | Bias Biological and medical sciences Data Interpretation, Statistical Evidence-based medicine Humans Internal validity Medical sciences Methodology Miscellaneous n-of-1 trial Novices Psychology. Psychoanalysis. Psychiatry Psychometric properties Psychometrics - methods Psychopathology. Psychiatry Randomized Controlled Trials as Topic - methods Ratings & rankings Research Design Revisions Revival Risk of bias Single-case experimental design Techniques and methods Validity |
Title | Revision of a method quality rating scale for single-case experimental designs and n-of-1 trials: The 15-item Risk of Bias in N-of-1 Trials (RoBiNT) Scale |
URI | https://www.tandfonline.com/doi/abs/10.1080/09602011.2013.824383 https://www.ncbi.nlm.nih.gov/pubmed/24050810 https://www.proquest.com/docview/1434760419 https://www.proquest.com/docview/1434742049 https://www.proquest.com/docview/1464512885 https://www.proquest.com/docview/1512191891 |
Volume | 23 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6FVEJcEG8CpVokDqBoq6yfa24tD1WI5hASUXGx_FhLUVM7SpND-Sn8FH4dMzvr2BZteFwsyzv2Wp7PszOz82DsVZrKUGeOxijxUHhRlgtY9LRIQJ2QrpcXrsJ859NxcDLzPp35Z73ez1bU0madHmbfr80r-R-uwjXgK2bJ_gNntw-FC3AO_IUjcBiOf8XjiU0NpyRHagZt0ySvhsha9BUAE6iwN3oFFlpksG51C_vnJoqDijWXoiqEHJpmHpd10If0Bfp4hxMbh348T0wY7ZiIp4aYnBHH8_EUPQ1fcNq25muqgCw74nbVqRLe-BCoY9-kSq_K4edGdgOUrVBrx_on1B2yPK9MYhIOzxar-Xmz5wQ68gXZCiW1Cq-9HLKJl4NFiiSzF3gCs3TboptSlS1E_ZYcDkgO_7Y-2IBKMNtM8Vac6VA5WK61TQ5fd3lhMAP6DmiwNvC2W5e7HrrF9hwwUZw-2zs6ef_t63YPS428oE7WxGru10yKpajtYzp6UadqLobrJgiWglqt3GwLGZ1oeo_dtcYMPyJk3mc9XT5gt09tuMZD9qMGKK8KnnACKLcA5QRQbgDK4UV4C6C8DVBuAcoBoJwAygmgbznAk1t4coQnzoTw5POSEzw5wZO_JnC-4Qaaj9js44fpuxNhm4GIDGzqtXADqfIww_jhMAC1OPEjD9XPQuejqNDYVkHnKI80qMQw4od5muaBm40K34nSyH3M-mVV6qeMK0dlMJwoKTMvwXpNoMaHShZRIp1MuwPm1qyIM_sPYMOWRSzrgrqWlzHyMiZeDpjY3rWkSjF_oFdtLsdr46GzPI7d3bcedBCxnc8JQeEEpX_A9muIxFZeXYKR78KnG3kyGrCX22FYTXCLMCl1tbE0HnzLnTSBB2aCUv4OGiAAYa8iOWBPCKLNS1rEP7tx5Dm708iAfdZfrzb6Bej-6_TA_mS_AASY-5U |
linkProvider | Library Specific Holdings |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELaglaAX3o9AKYPEAQ5e4jgPhxtFVKF097BsJW5R4jho1SqpSPYAP4Vfy0zsLF2kLhJccvE4jidj-xt7_A1jL8tSJEYHhqLEEx6muuK46BleIJwQMqxqqei-83QWZ6fh8ZdojCbsXFgl-dC1JYoY5moa3LQZPYbEvSHYPZBv4kNOVEB0m9fZbpSGEv2v3cX8OMvWRwnKt7d1sA6nSuP9uSves7E-bbCXUthk0aHmapvy4mpMOqxNR7dZOfbKhqScTVZ9OdE__iB8_K9u32G3HHKFd9bU7rJrprnHbkzd2fx99nPuLqpDW0MBNjU12Eub34EMrfkK1DED2FugPYpzwzWuonA5zQBUQ0xJB_id0PC25gKG1CLdW0CbBhFx2m-G-bI7o5YOl0UHywZmVnQxiMKreXu4nC1ew2dq8AE7PfqweJ9xl_mBa3Sgei5joapEU7BoEiMGKvDXEtaoTeWntSEOfVOR8RnEP1gSJVVZVrHUfh0FaZnKh2ynaRvzmAF6lBqLCyWEDgsi50HMlihRp4UItJEek-P_zrWjRafsHOe5GNlTndpzUntu1e4xvq51YWlB_iKvLptS3g_bMc6Qcrm96sGG2a3bCxJEF4jwPLY_2mHuJqAOPTqJqvNDkXrsxboYpw46Dyoa066cTIi63CoTh4gJlYq2yKAAjmyVCo89suPg90eiQ4Co03_y7wp4zm5mi-lJfvJx9ukp26MSG025z3b6byvzDFFhXx64cf8LVPpP7g |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELaglSouvB-BUgaJAxy8jfN0uFFgtRS6QstW6i1KHButWiUVyR7gp_BrmYmdZRepiwSXHNbjOJ4d25_tmW8Ye1GWItUq0OQlnvIoUxXHRU_zAuGECKPKhJLinU-myeQ0Oj6Lz9ai-MmtkvbQxhJF9HM1De7LygwecYeEunvuTXyEIxkQ2-Z1tos_Bmjju_PZ8WSyukmQvg3WwTqcKg3hc1e8Z2N52iAvJa_JokXFGZvx4mpI2i9N41usGDplPVLOR8uuHKkff_A9_k-vb7ObDrfCG2tod9g1Xd9leyfuZv4e-zlzYerQGCjAJqYGG7L5HcjM6q9A_dKAnQU6objQXOEaCutJBqDqPUpawM-EmjeGC-gTi7SvAS0aRMzptBlmi_acWjpaFC0sapha0XkvCi9nzdFiOn8FX6jB--x0_H7-dsJd3geucPvU8TARskoVuYqmCSKgIs4iQhpGV35mNDHo64pMTyP6wZI4rcqySkLlmzjIyix8wHbqptaPGOB-UmFxIYVQUUHUPIjYUilMVohA6dBj4fB358qRolNujotcDNypTu05qT23avcYX9W6tKQgf5GX65aUd_1hjLOjPNxe9WDD6lbtBSliC8R3HtsfzDB300-L-7kQVedHIvPY81UxThx0G1TUulk6mQh1uVUmiRARShlvkUEBHNcyEx57aIfB74_E7QBiTv_xvyvgGdv7_G6cf_ow_fiE3aAC60q5z3a6b0v9FCFhVx64Uf8L29NOkg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Revision+of+a+method+quality+rating+scale+for+single-case+experimental+designs+and+n-of-1+trials%3A+the+15-item+Risk+of+Bias+in+N-of-1+Trials+%28RoBiNT%29+Scale&rft.jtitle=Neuropsychological+rehabilitation&rft.au=Tate%2C+Robyn+L&rft.au=Perdices%2C+Michael&rft.au=Rosenkoetter%2C+Ulrike&rft.au=Wakim%2C+Donna&rft.date=2013-10-01&rft.eissn=1464-0694&rft.volume=23&rft.issue=5&rft.spage=619&rft_id=info:doi/10.1080%2F09602011.2013.824383&rft_id=info%3Apmid%2F24050810&rft.externalDocID=24050810 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0960-2011&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0960-2011&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0960-2011&client=summon |